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Abstract
Introduction: Sepsis is the leading cause of acute kidney injury (AKI) in critical patients. The optimal timing of
initiating renal replacement therapy (RRT) in septic AKI patients remains controversial. The objective of this study is to
determine the impact of early or late initiation of RRT, as defined using the simplified RIFLE (risk, injury, failure, loss of
kidney function, and end-stage renal failure) classification (sRIFLE), on hospital mortality among septic AKI patients.
Methods: Patient with sepsis and AKI requiring RRT in surgical intensive care units were enrolled between January
2002 and October 2009. The patients were divided into early (sRIFLE-0 or -Risk) or late (sRIFLE-Injury or -Failure)
initiation of RRT by sRIFLE criteria. Cox proportional hazard ratios for in hospital mortality were determined to
assess the impact of timing of RRT.
Results: Among the 370 patients, 192 (51.9%) underwent early RRT and 259 (70.0%) died during hospitalization.
The mortality rate in early and late RRT groups were 70.8% and 69.7% respectively (P > 0.05). Early dialysis did not
relate to hospital mortality by Cox proportional hazard model (P > 0.05). Patients with heart failure, male gender,
higher admission creatinine, and operation were more likely to be in the late RRT group. Cox proportional hazard
model, after adjustment with propensity score including all patients based on the probability of late RRT, showed
early dialysis was not related to hospital mortality. Further model matched patients by 1:1 fashion according to
each patient’s propensity to late RRT showed no differences in hospital mortality according to head-to-head
comparison of demographic data (P > 0.05).
Conclusions: Use of sRIFLE classification as a marker poorly predicted the benefits of early or late RRT in the
context of septic AKI. In the future, more physiologically meaningful markers with which to determine the optimal
timing of RRT initiation should be identified.
Introduction
Acute kidney injury (AKI) is a common entity in criti-
cally ill patients with an incidence of about 30 to 60%
[1] as defined by the RIFLE (risk, injury, failure, loss of
kidney function, and end-stage renal failure) classifica-
tion and is thought to be an independent risk factor for
increased morbidity and mortality [2-4]. Sepsis is the
leading cause of AKI, contributing to 30 to 50% of cases
of AKI [4,5]. Almost 30% of septic AKI patients need
renal replacement therapy (RRT). This rate is much
higher than that observed for other causes of AKI [6-8].
Among critically ill patients, mortality rates of patients
with septic AKI are also higher than among patients
with non-septic AKI [9]. Thus, finding better strategies
for septic AKI is the key issue for intensivists. The cur-
rent goal is to improve strategies for the treatment of
patients with septic AKI.
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medium, provided the original work is properly cited.The pathogenesis of sepsis is a systemic inflammatory
reaction that involves multiple inflammatory mediators.
Many strategies for treatment were recommended as
part of the early goal-directed therapy popularized by
the Surviving Sepsis Campaign (SSC) [10]. Although
RRT for refractory fluid overload, as well as electrolyte
and acid-base imbalance, is recommended by the SSC,
issues related to when and how to perform RRT are not
addressed. Furthermore, continuous RRT (CRRT) with
high-volume hemofiltration and a super-high flux dialy-
zer was suggested to restore immune homeostasis by
removing cytokines and toxic molecules, but the effects
on morbidity and mortality are still controversial [11,12].
As inflammatory cytokines play a critical role in the
mechanism of septic AKI as compared with other etiolo-
gies of AKI [13], we hypothesized that the timing of
RRT initiation in septic AKI is more important than in
other types of AKI. However, certain observational stu-
dies showed that early initiation of RRT may be better
for critically ill patients with severe AKI [14,15]. There
is still no strong evidence or clear definition of how
early is early enough. However, the RIFLE classification
was used widely to categorize the severity of AKI, and
was able to predict patient outcomes in some studies
[16]. The purpose of the current study is to test the
hypothesis that the timing of RRT initiation, as defined
using sRIFLE criteria, is associated with patient out-
comes, using our NSARF (National Taiwan University
Hospital Study group on Acute Renal Failure) database.
Materials and methods
Study populations
This retrospective study was based on the NSARF data-
base, which was established in the 64-bed surgical ICU
of a tertiary hospital and its three branch hospitals in
different cities [17-20]. The database prospectively col-
lected data from patients requiring RRT during their
ICU stays, and continuously recorded data from all
patients for outcome analyses. In this study, we enrolled
patients who underwent acute RRT because of septic
AKI between July 2002 and October 2009. Those
enrolled subjects were treated by one multi-modality
team, composed of physicians, surgeons, technicians,
and nursing personel. Septic AKI was defined as AKI
development after sepsis without other etiology. Sepsis
was classified according to the American College of
Chest Physicians and the Society of Critical Care Medi-
cine consensus [21]. Sepsis was defined by the presence
of both infection and systemic inflammatory response
syndrome (SIRS). SIRS was considered to: be present
when patients had more than one of the following clini-
cal findings: body temperature above 38°C or below 36°
C, heart rate of more than 90 beats/min, hyperventila-
tion evidenced by a respiratory rate of more than 20
breaths/min or a partial pressure of arterial carbon
dioxide of less than 32 mmHg, and a white blood cell
c o u n to fm o r et h a n1 2×1 0
3 cells/μlo rl e s st h a n4×
10
3 cells/μl. Infection was defined as a pathologic pro-
cess caused by the invasion of normally sterile tissue or
fluid or body cavity by pathogenic or potentially patho-
genic microorganisms. Exclusion criteria included
patients aged less than 18 years, patients with an ICU
stay of less than two days [22], and patients who only
underwent acute RRT for less than two days. Approval
f o rt h i ss t u d yw a so b t a i n e df r o mt h eI n s t i t u t i o n a l
Review Board of National Taiwan University Hospital,
Taipei, Taiwan (No. 31MD03). Informed consent was
waived because there was no breach of privacy and the
study did not interfere with clinical decisions related to
patient care.
Data collection
All data were prospectively collected. Data variables
included demographic data, comorbid diseases, septic
AKI developed post-surgery (or not), and the indications
for RRT. Biochemistry data such as complete blood cell
count, blood urea nitrogen (BUN), serum creatinine
(sCr), serum glutamate oxaloacetate transaminase
(GOT), serum total bilirubin, serum albumin, and serum
potassium (sK
+) were recorded upon ICU admission and
RRT initiation [18,20]. Moreover, the clinical parameters
and severity score were also recorded at these two time
points. The clinical parameters included heart rate, sys-
tolic and diastolic blood pressures, central venous pres-
sure (CVP) level, partial pressure of arterial blood gas
oxygen and fraction of inspired oxygen. Severity scores
included Glasgow Coma Scale( G C S )s c o r e ,A c u t eP h y -
siology and Chronic Health Evaluation II (APACHE II)
score [23], Sequential Organ Failure Assessment (SOFA)
score [24], and Simplified Acute Physiology Score III
(SAPS III) [25]. The usage of mechanical ventilation was
recorded and the inotropic equivalent dose was calcu-
lated [26]. Definitions were made as follows: hyperten-
sion was blood pressure above 140/90 mmHg or usage
of anti-hypertension agents; diabetes was previous usage
of insulin or oral hypoglycemic agents; congestive heart
failure was low cardiac output with a CVP above 12
mmHg and dopamine equivalent above 5 μg/kg/min
[26]; and chronic kidney disease (CKD) was sCr of 1.5
mg/dl or greater documented prior to this admission.
The indications for RRT were: (1) azotemia (BUN >
80 mg/dL and sCr > 2 mg/dl) with uremic symptoms;
( 2 )o l i g u r i a( u r i n ea m o u n t< 1 0 0m le v e r ye i g h th o u r s )
or anuria refractory to diuretics; (3) fluid overload
refractory to diuretics with a CVP level above 12 mmHg
or pulmonary edema with a partial pressure of arterial
oxygen/fraction of inspired oxygen ratio below 300
mmHg; (4) hyperkalemia (sK
+ > 5.5 mmol/L) refractory
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<7.2 in arterial blood gas) [27].
According to previous studies [2,28,29], simplified
RIFLE classification was used only with the glomerular
filtration rate (GFR) criterion for classification because
the eight-hourly urine volumes in our database did not
match the 6- or 12-hourly urine output criterion in the
RIFLE classification. The baseline sCr was the data
acquired at hospital discharge from the prior admission
among the patients with more than one admission [2],
or the data estimated using the Modification of Diet in
Renal Disease (MDRD) equation [30] in those with only
one admission (assuming an average estimated GFR of
75 ml/min/1.73 m
2). The peak sCr was defined as the
highest sCr before RRT initiation in ICU. Those who
initiated RRT when in sRIFLE-R (risk) or sRIFLE-0 [31],
that is not yet reaching the sRIFLE-R level, were defined
as the early dialysis (ED) group, while those in the sRI-
FLE-I (injury) or sRIFLE-F (failure) groups were classi-
fied as the late dialysis (LD) group.
The choice of RRT modality
The modality of RRT was chosen according to the
hemodynamics of the patients. Continuous venovenous
hemofiltration was performed if more than 15 points
o fi n o t r o p i ce q u i v a l e n t( I E )[ 2 6 ]w e r er e q u i r e dt o
maintain systemic blood pressure up to 120 mmHg.
The effluent flow and blood flow were 35 ml/kg/hour
and 200 ml/min, respectively. Extended RRT such as
sustained low efficiency RRT (SLED) with or without
hemofiltration (SLED-f) was performed if IE was
between 5 and 15 points. For SLED, blood flow and
dialysate flow were 200 ml/min and 300 ml/min,
respectively. When hemofiltration was added, the
hemofiltration rate was 35 ml/kg/hour. The duration
of hemofiltration was about 6 to 12 hours, according
to the amount of ultrafiltration. Intermittent hemodia-
lysis, which was chosen if IE was less than five points,
was performed for four hours every session with a dia-
lysate flow of 500 ml/min, and blood flow of 200 ml/
min. As hemodynamics change, the patients may
receive different RRT modalities [19].
Outcomes
The endpoint of this study was in-hospital mortality.
The survival period was calculated from RRT initiation
to mortality (in non-survivors) or to hospital discharge
(in survivors).
Statistics
Statistical analyses were performed using SAS, version
9.1.3 (SAS Institute Inc., Cary, NC, USA), statistical soft-
ware. In statistical testing, a two-sided P value of less
than 0.05 was considered statistically significant.
Continuous data were expressed as mean ± standard
deviation unless otherwise specified. Frequency and per-
centage were calculated for categorical variables. Stu-
dent’s t test was used to compare the means of
continuous data between two groups, whereas Chi-
s q u a r e dt e s to rF i s h e r ’s exact test was used to analyze
categorical proportions.
Then we used the backward stepwise likelihood ratio
model of Cox proportional hazard method to analyze
the independent predictors of in hospital mortality as
model 1. The independent variables were selected for
multivariate analysis if they had a P ≤0.2 on univariate
analysis. The basic model-fitting techniques for (1) vari-
able selection, (2) goodness-of-fit assessment, and (3)
regression diagnostics (e.g., residual analysis, detection
of influential cases, and check for multicollinearity) were
used in our regression analyzes to ensure the quality of
the analysis results.
Propensity matching
To balance the selection bias in an observational trial
such as the current study, we used propensity score
selection and the matching method [32,33]. Further
models were adapted in our study. In model 2, we con-
ducted Cox proportional hazard models using a propen-
sity score, and included all patients based on the
probability of late RRT. In model 3, we identified factors
associated with late RRT in the entire cohort, using
stepwise logistic regression. Based on the factors identi-
fied, we matched patients with 1:1, 2:2, 3:3, or 4:4 blocks
manually [32]. We subsequently compared outcomes
between patients undergoing early dialysis or late dialy-
sis. In addition, a sensitivity analysis was also carried out
among the subset of patients undergoing dialysis due to
azotemia, which represented the largest proportion of
our study population.
Finally, Kaplan-Meier curves obtained with the log-
rank test were plotted to demonstrate the differences in
patient survival between the two groups (ED versus LD).
Results
From our database, we identified 1,258 patients who
underwent RRT during the study period. Among these
patients, 370 fulfilled our enrollment and exclusion cri-
teria for septic AKI. The mean age of enrolled patients
was 65.4 ± 15.9 years on the day of RRT. Males
accounted for 67.0% of patients. The basic demographic
data on enrollment and on ICU admission and acute
physiology scores are shown in the upper part of Table
1. Finally, 192 (51.9%) patients underwent early RRT
and the rest (48.1%) received late RRT. In-hospital mor-
tality affected 279 patients (70%). Hospital mortality
rates were comparable in these two groups (70.8% vs.
69.7%, respectively; P = 0.98).
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RRT groups (n = 370)
Enrolled patients (n = 370) Early RRT (n = 192) Late RRT (n = 178) P-value
Demographic data
Age (years) 65.4 ± 15.9 64.1 ± 16.5 66.7 ± 15.2 0.34
Male (%) 248 (67.0) 119 (62) 129 (72.5) 0.04
DM (%) 126 (34.1) 63 (32.8) 63 (35.5) 0.68
Hypertension(%) 175 (47.3) 92 (47.9) 83 (46.6) 0.93
CHF (%) 68 (18.4) 44 (22.9) 24 (13.5) 0.02
CKD (%) 92 (24.9) 56 (29.2) 36 (20.2) 0.06
Post-operative (%) 237 (64.1) 113 (58.9) 124 (69.7) 0.03
Admission creatinine (mg/dL) 2.0 ± 0.2 2.7 ± 1.7 1.5 ± 1.0 < 0.01
(μmol/L) 176.6 ± 17.7 238.7 ± 150.3 132.6 ± 88.4
Mechanical ventilation (%) 322 (87.0) 163 (84.9) 159 (89.3) 0.27
Data at ICU admission
Hematocrit (%) 32.2 ± 9.5 32.3 ± 12.0 32.1 ± 5.9 0.83
BUN (mg/dL) 50.7 ± 33.7 59.8 ± 34.1, 41.0 ± 30.4, 0.05
(mmol/L) 18.1 ± 12.0 21.3 ± 12.2 14.6 ± 10.9
Creatinine (mg/dL) 2.5 ± 1.7 2.6 ± 1.8 2.3 ± 1.6 0.06
(μ mol/L) 221 ± 150.3 232.5 ± 156.5 200.7 ± 141.4
Albumin (g/dL) 2.9 ± 0.7 3,0 ± 0.7 2.9 ± 0.7 0.08
(g/L) 29 ± 7 30 ± 7 29 ± 7
APACHE II scores 11.3 ± 6.4 11.8 ± 6.6 10.7 ± 6.0 0.37
SOFA scores 8.1 ± 3.8 8.7 ± 3.7 7.4 ± 3.8 0.18
SAPS III score 63.1 ± 13.0 64.7 ± 7.3 62.2 ± 7.6 0.30
Pre-RRT data
Hematocrit (%) 30.0 ± 5.8 30.1 ± 6.3 29.8 ± 0.6 0.62
BUN (mg/dL) 81 ± 40.6 78.2 ± 41.2 84.0 ± 39.8 0.19
(mmol/L) 28.9 ± 14.5 27.9 ± 14.7 30.0 ± 14.2
Creatinine (mg/dL) 3.4 ± 0.4 3.4 ± 0.3 3.4 ± 0.8 0.17
(μmol/L) 298.8 ± 35.4 297.9 ± 23.9 299.7 ± 70.7
Albumin (g/dL) 3.0 ± 1.2 3.1 ± 1.5 2.9 ± 0.6 0.09
(g/L) 30 ± 12 31 ± 15 29 ± 6
Potassium (mEq/L) 4.8 ± 12.1 5.0 ± 1.0 4.3 ± 0.9 0.32
Lactate (mg/dL) 3.4 ± 3.6 3.5 ± 3.9 3.1 ± 3.5 0.10
(mmol/L) 0.4 ± 0.4 0.4 ± 0.4 0.3 ± 0.4
GCS scores 11.8 ± 3.7 11.5 ± 4.3 11.0 ± 4.5 0.72
Systolic blood pressure 122.7 ± 25.7 122.8 ± 26.5 123.7 ± 25.7 0.84
Diastolic blood pressure 61.2 ± 39.0 61.5 ± 14.1 60.1 ± 14.0 0.36
Central venous pressure 13.8 ± 5.5 14.16 ± 5.9 13.4 ± 5.2 0.22
APACHE II scores 13.1 ± 6.4 12.3 ± 7.0 14.0 ± 5.5 0.52
SOFA scores 11.2 ± 3.9 10.8 ± 4.0 11.6 ± 3.7 0.80
SAPS III score 67.3 ± 6.8 66.2 ± 6.7 68.6 ± 6.7 0.61
Indications for dialysis
Azotemia with uremic symptoms 265 (71.6) 119 (62.0) 146 (82.0) < 0.01
Oligouria or anuria 241 (65.1) 113 (58.9) 128 (63.0) 0.01
Fluid overload 81 (21.9) 41 (21.4) 40 (22.5) 0.29
Electrolyte imbalance 23 (6.2) 8 (4.2) 15 (8.4) 0.14
Acid base imbalance 25 (6.8) 12 (6.4) 13 (7.3) 0.84
Rhabdomyolysis 7 (1.9) 5 (2.7) 2 (1.1) 0.51
Hospital mortality 259 (70.0) 135 (70.8) 124 (69.7) 0.98
Values are presented as mean ± standard deviation or number (percentage) unless stated otherwise.
APACHE II: Acute Physiology and Chronic Health Evaluation II; BUN: blood, urea, nitrogen; CHF: congestive heart failure; CKD: chronic kidney disease; DM:
diabetes mellitus; GCS: Glasgow Coma Scale; RRT: renal replacement therapy; SAPS: Simplified Acute Physiology Score; SOFA: Sequential Organ Failure
Assessment.
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Cox proportional hazard model were conducted with the
whole cohort to identify factors associated with in-hospi-
tal mortality. We found that patients underwent opera-
tions before RRT (hazard ratio (HR) = 0.631, P = 0.0011),
pre-RRT CVP (HR = 1.030, P = 0.0140), pre-RRT diasto-
lic blood pressure (HR = 0.987, P = 0.0089), pre-RRT
GCS scores (HR = 0.929, P < 0.001), pre-RRT plasma lac-
tate (mM) (HR = 1.086, P < 0.001), SOFA score on ICU
admission (HR = 0.941, P = 0.0015), and SOFA scores on
RRT commencement (HR = 1.068, P = 0.0058) were
independently associated with in-hospital mortality.
Model 2: propensity score adjusted methods (Table 2)
The Cox proportional hazard model was conducted
using the whole cohort, including propensity score as a
covariate, and identified pre-RRT diastolic blood pres-
sure (HR = 0.987, P = 0.013), pre-RRT GCS scores (HR
=0 . 9 2 3 ,P < 0.001), pre-RRT lactate (mM) (HR = 1.073,
P < 0.001), pre-RRT SOFA score (HR = 1.104, P <
0.001), and SOFA score on ICU admission (HR = 0.934,
P < 0.001) predicted in-hospital mortality when propen-
sity scores were conditioned (HR = 0.085, P < 0.001).
Model 3: propensity score matching method
By logistic regression, we identified differences between
early RRT and late RRT groups, and found that male
patients (odds ratio (OR) = 1.588, 95% confidence inter-
val (CI) = 1.012 to 2.492, P = 0.0444), patients with
CHF (OR = 0.520, 95% CI = 0.297 to 0.909, P = 0.0217),
patients receiving operations (OR = 1.618, 95% CI =
1.041 to 2.516, P = 0.0326), and patients with higher
admission creatinine (OR = 1.184, 95% CI = 1.051 to
1.333, P = 0.0055) could predicted late dialysis. This
model had a good discriminating power (c-index =
0.637), and validation (Hosmer-Lemshow’s statistics, P =
0.07, with chi squared = 14.6, df = 8) was fair.
We matched patients by 1:1 fashion according to each
patient’s propensity to late RRT. After careful matching,
there were 178 patients in each cohort. Table 3 showed
the demographic data of the matched cohort. No differ-
ences about hospital mortality were detected in both
groups according to head-to-head comparison of demo-
graphic data. Log Rank test of Kaplan-Meier curves (Fig-
ure 1) was insignificant between these two groups (HR =
1.13, P = 0.33).
Further sensitivity analyzes were undertaken using
patients undergoing RRT because of uremic symptoms.
Hospital mortality was associated with post-operative
status (HR = 0.651, P =0 . 0 0 2 ) ,p r e - R R TC V Pl e v e l( H R
= 1.031, P = 0.002), pre-RRT diastolic blood pressure
(HR = 0.9687, P = 0.0029), pre-RRT GCS scores (HR =
0.969, P < 0.0001), pre-RRT lactate level (HR = 1.091, P
< 0.0001), SOFA score on ICU admission (HR = 0.921,
P = 0.0033), and SOFA score on starting RRT (HR =
1.071, P = 0.0021).
Discussion
Whether or not to perform and when to start RRT in
patients with AKI are two dilemmas facing intensivists.
There is still no consensus and the initiation of RRT is
extremely variable and based primarily on empiricism,
local institutional practice, and resources [5,34,35]. Tra-
ditional indications for RRT among end-stage renal dis-
ease patients were not appropriate for AKI patients. The
concepts of renal support for AKI patients were estab-
lished in 2001 by Mehta [36]. Some indicators for RRT
and renal support are the same in life-threatening condi-
tions such as severe hyperkalemia, marked acid-base dis-
turbances, or diuretic-resistant pulmonary edema. Other
indications may differ between patients with end-stage
renal disease and AKI. For instance, many studies have
found that even mild increases in sCr in AKI patients
have significant impact on outcome [37]. Interventions
should be performed earlier and dialysis may be consid-
ered if residual renal function cannot support the patient.
As patients who received dialysis too early would be
exposed to unnecessary risk of dialysis, while those
Table 2 Independent predictors of in-hospital mortality obtained using the Cox proportional hazards model
Variables Unadjusted (model 1) Propensity score adjusted (model 2)
HR 95% CI P-value HR 95% CI P-value
Post-operative, yes 0.631 0.478 - 0.832 0.0011
Pre-RRT CVP (mmHg) 1.030 1.006 - 1.055 0.0140
Pre-RRT DBP (mmHg) 0.987 0.977 - 0.997 0.0089 0.987 0.977 - 0.997 0.013
Pre-RRT GCS scores 0.929 0.898 - 0.962 < 0.001 0.923 0.890 - 0.958 < 0.001
Pre-RRT lactate (mM) 1.086 1.048 - 1.124 < 0.001 1.073 1.034 - 1.113 < 0.001
SOFA score on ICU admission 0.941 0.907 - 0.977 0.0015 0.934 0.900 - 0.970 < 0.001
SOFA score pre-RRT 1.068 1.019 - 1.120 0.0058 1.104 1.051 - 1.160 < 0.001
Propensity scores - - - 0.085 0.027 - 0.268 0.085
95% CI: 95% confidence interval; CVP: central venous pressure; DBP: diastolic blood pressure; GCS: Glasgow Coma Scale; HR: hazard ratio; RRT: renal replacement
therapy; SOFA: Sequential Organ Failure Assessment.
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lishing reliable indications for RRT in patients with AKI
is important. In many studies, BUN and sCr are used to
categorize early and late dialysis patients. This topic has
been debated since the 1960s [38]. The first result of
improved survival rates in patients dialyzed with a lower
starting BUN was published by Teschan et al [39].
Regarding recent studies, some retrospective studies
reported better survival among patients with post-trau-
matic and post-operation AKI who received early RRT.
[40-42]. However, other studies found no difference in
survival in the early-dialyzed group of critically ill
patients [14,15,43]. It is difficult to compare or perform
meta-analysis among the aforementioned studies due to
the lack of consensus on the definitions of early and late
RRT. Due to extensive validation of the RIFLE classifica-
tion, some studies have used it to evaluate the relation
between prognosis and RRT timing [28,42].
Our study focused on the impact of timing for septic
AKI because of the unique pathogenesis of septic AKI,
which involves a deleterious inflammatory cascade
mediated by cytokines and toxic molecules. Some stu-
dies have demonstrated improvement in hemodynamics
and mortality by RRT [13]. However, there are very few
reports addressing the impact of RRT timing on septic
AKI. A study by Liu et al.[ 1 5 ]i n c l u d e dn u m e r o u s
patients who had sepsis or septic shock (37% in the
early group and 46% in the late group) and is the first
study to address the timing of RRT in critically ill septic
patients. Also, the most common cause of AKI in the
Table 3 Comparisons of demographic data and clinical
parameters between matched early, and late RRT groups
(model 3)
Early RRT (n =
178)





Age (years) 65.2 ± 15.6 66.7 ± 15.2 0.71
Male (%) 63.5 72.5 0.07
DM (%) 32.7 35.5 0.71
Hypertension (%) 47.8 46.6 0.83
CHF (%) 17.4 13.5 0.38
CKD (%) 28.1 20.2 0.06
Post-operative(%) 62.9 69.7 0.21
Admission creatinine
(mg/dL)
1.9 ± 1.1 1.5 ± 1.0 0.07




Data at ICU admission
Hematocrit (%) 32.2 ± 12.1 32.1 ± 5.9 0.17
BUN (mg/dL) 50.8 ± 34.4 41.0 ± 30.4 0.07
(mmol/L) 18.1 ± 12.2 14.6 ± 10.9
Creatinine (mg/dL) 2.9 ± 1.8 2.3 ± 1.6 0.13
(μmol/L) 247.5 ± 159.1 200.7 ± 141.4
Albumin (g/dL) 2.9 ± 0.6 2.9 ± 0.7 0.13
(g/L) 29 ± 6 29 ± 7
APACHE II scores 11.9 ± 6.8 10.7 ± 6.0 0.83
SOFA scores 8.9 ± 3.7 7.4 ± 3.8 0.61
SAPS III score 60.7 ± 12.3 62.2 ± 7.6 0.25
Pre-RRT data
Hematocrit (%) 30.0 ± 6.2 29.8 ± 0.6 0.19
BUN (mg/dL) 79.1 ± 41.4 84.0 ± 39.8 0.26
(mmol/L) 28.3 ± 14.8 30.0 ± 14.2
Creatinine (mg/dL) 3.4 ± 1.9, 3.4 ± 0.8 0.25
(μmol/L) 300.6 ± 168.0 299.7 ± 70.7
Albumin (g/dL) 3.1 ± 1.5 2.9 ± 0.6 0.10
(g/L) 31 ± 15 29 ± 6
Potassium (mEq/L) 5.1 ± 1.0 4.3 ± 0.9 0.16
Lactate (mg/dL) 3.4 ± 3.6 3.1 ± 3.5 0.14
(mmol/L) 0.4 ± 0.4 0.3 ± 0.4
GCS scores 11.7 ± 4.2 11.0 ± 4.5 0.40
Systolic blood pressure 123.5 ± 26.7 123.7 ± 25.7 0.37
Diastolic blood pressure 64.6 ± 54.3 60.1 ± 14.0 0.35
Central venous pressure 14.3 ± 5.7 13.4 ± 5.2 0.85
APACHE II scores 12.3 ± 6.7 14.0 ± 5.5 0.34
SOFA scores 10.9 ± 4.1 11.6 ± 3.7 0.13
SAPS III score 66.3 ± 6.8 68.6 ± 6.7 0.79
Hospital mortality (%) 70.8 69.7 0.98
Values are presented as mean ± standard deviation or number (percentage)
unless otherwise stated.
APACHE II: Acute Physiology and Chronic Health Evaluation II; BUN: blood,
urea, nitrogen; CHF: congestive heart failure; CKD: chronic kidney disease; DM:
diabetes mellitus; GCS: Glasgow Coma Scale; RRT: renal replacement therapy;
SAPS: Simplified Acute Physiology Score; SOFA: Sequential Organ Failure
Assessment.
Figure 1 Comparison of cumulative patient survival between
early and late dialysis groups, as defined by the sRIFLE
classification. By Kaplan-Meier method. Dashed line, late dialysis
group (sRIFLE-I and sRIFLE-F). Solid line, early dialysis group (sRIFLE-0
and sRIFLE-R). RRT: renal replacement therapy.
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the study was not specifically designed to look at timing
of RRT in critically ill patients with sepsis, and their
definitions of timing were different. Our previous study
found that late initiation of RRT was associated with
worse outcomes in AKI after major abdominal surgery
[42]. The patients were divided to ED (simplified RIFLE-
0 or Risk) and LD (simplified RIFLE-Injury or Failure)
groups; 27.5% and 36.2% patients in the early and late
RRT groups, respectively, had sepsis. Carl et al.r e t r o -
spectively reviewed the effect of timing of RRT on mor-
tality among critically ill, septic patients with AKI [44].
They found survival rates for the ED group were signifi-
cantly higher than that in the LD group.
Although we matched early and late RRT groups with
propensity score, there was still no survival benefit in
the early RRT group. One possibility is that our patients
may receive different modalities, depending on their
hemodynamics. Therefore, there was no fixed dose or
modality during RRT that influenced the outcome.
Another reason may be that traditional markers were
not sufficiently sensitive to detect AKI early on. For
example, Doi et al. found that creatinine production is
reduced in sepsis [45]. As Gibney et al.a n dM a c e d oet
al. recently reported, it is reasonable to combine other
independent predictors of varying weight to calculate an
index for use by intensivists in determining the optimal
timing of RRT initiation [46,47].
I nt h ep r o p e n s i t ys c o r ea d j u s t e dm o d e l ,w ef o u n d
some predictors of in-hospital mortality among septic
AKI patients (Table 2). Lower pre-RRT diastolic blood
pressure, lower pre-RRT GCS scores, and higher pre-
RRT lactate level may be due to poor heart function
and poor tissue perfusion, which resulted in poor out-
come [14,48]. In addition, higher ICU admission and
pre-RRT SOFA score predicted a higher risk of death.
T h eS O F As c o r eh a sb e e nr e p o r t e dt ob eap r o g n o s t i c
factor in other studies [29,49].
Limitations and summary
As an observational study, this investigation has several
limitations to be addressed. First, only the estimated
GFR criterion of the RIFLE classification was used in
this study. Urine output may also be an important indi-
cation for initiation of RRT. Thus we used the term
‘sRIFLE’ to distinguish this classification from the origi-
nal RIFLE. Second, our patients received different mod-
alities as dictated by their individual hemodynamics.
Therefore, we were not able to manage the impact of
different doses and modalities. Third, we only included
patients who actually underwent RRT. There will be a
subset of patients with AKI who are not dialyzed “early”
who never undergo RRT because they either die or
recover kidney function before meeting the “late”
criteria for RRT. Fourth, we did not correct sCr by the
degree of fluid [50].
Conclusions
Patients with AKI associated with sepsis carry substan-
tial risks for adverse outcomes, especially those who
need RRT. Timely RRT has been proposed as an attrac-
tive modality to improve patient outcomes in septic AKI
patients; but our current analyzes did not support early
RRT, as defined with sRIFLE classification. Future
research efforts should seek to identify more physiologi-
cally meaningful markers to determine the optimal tim-
ing of RRT initiation.
Key messages
￿ Timely RRT initiation in patients with septic AKI is
important, but previous studies did not demonstrate
strong evidence or clear definition of how early is early
enough.
￿ Pre-RRT diastolic blood pressure, pre-RRT GCS
scores, pre-RRT lactate level, pre-RRT SOFA score, and
SOFA score on ICU admission predicted in-hospital
mortality.
￿ Early or late RRT, as defined with simplified RIFLE
classification, could not predict in-hospital mortality.
￿ More physiologically meaningful markers with which
to determine the optimal timing of RRT initiation
should be identified.
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